The results indeed point out that the FM group with ME/CFS co-diagnosis (n = 19) does not seem to respond to MT by increasing their CX3CR1 levels, while DE of HBEGF and EGR2 appears more related to this group (Figure 6). This evidence concerns the gene CX3CR1 and myalgic encephalomeyelitis/chronic fatigue syndrome.